ASTRAL NEUTRONICS LTDActive

Company number 13376789Private limited companyIncorporated 2021

Key figures

£1,840,887-45.6%
Net assets 2025
+605.0%
Average annual growth 2021/22–2025
01 m2 m3 m4 m2021/222022/2320242025

Like most small UK companies, ASTRAL NEUTRONICS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2021/222022/2320242025
Filed accounts2021/22–2025
2021/222022/2320242025
Turnover—205,865——
Profit for the year—84,859——
Cash at bank and in hand——2,845,386239,501
Total assets7,636133,4743,385,7711,913,948
Total liabilities2,3832,383——
Net assets / total equity5,253114,2913,385,7711,840,887
Average number of employees221522
Average pay (per year)—16,218——

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ASTRAL NEUTRONICS LTD

Company

ASTRAL NEUTRONICS LTD is a private limited company registered with Companies House under company number 13376789. It was incorporated on 5 May 2021. Its status is active. The registered office is in Bristol (BS10). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), manufacture of irradiation, electromedical and electrotherapeutic equipment (26600), technical testing and analysis (71200), other research and experimental development on natural sciences and engineering (72190).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £1,840,887, down 45.6% on the previous year. Cash at bank and in hand was £239,501. The company had an average of 22 employees. Figures are available for 4 financial years (2021/22–2025).

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 3 Feb 2027.